NOX 6.45% 8.7¢ noxopharm limited

My interest is in whether Veyonda consistently prevented...

  1. 121 Posts.
    lightbulb Created with Sketch. 52
    My interest is in whether Veyonda consistently prevented patients from deteriorating from moderate status. Recognising of course that the focus of the trial was safety, not efficacy.
    Last edited by pohutukawa: 08/03/21
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
-0.006(6.45%)
Mkt cap ! $25.42M
Open High Low Value Volume
9.2¢ 9.2¢ 8.3¢ $44.27K 511.9K

Buyers (Bids)

No. Vol. Price($)
1 17000 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 22476 2
View Market Depth
Last trade - 15.41pm 15/08/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.